Literature DB >> 25916477

[Basic biochemical processes in glaucoma progression].

N von Thun und Hohenstein-Blaul1, S Kunst, N Pfeiffer, F H Grus.   

Abstract

The term glaucoma summarizes a group of eye diseases that are accompanied by impairments of the optic nerve and related visual field deficits. An early diagnosis of glaucoma is currently not possible due to a lack of diagnostic tests; therefore, in most cases the disease is diagnosed many years after onset, which prevents an early therapy. The known risk factors for the development and progression of glaucomatous optic neuropathy comprise elevated intraocular pressure and a broad range of pressure fluctuations as well as lipometabolic disorders, genetic factor and diabetes. The consequences include the induction of anti-inflammatory proteins, elevated levels of oxidative stress and the destruction of retinal ganglion cells. Changes in the autoantibody repertoire have also been observed in the course of the disease. Basic ophthalmological research therefore focuses on the investigation of basic biochemical processes in the course of the disease. A better understanding of physiological and biochemical events is sought in order to develop new and more sensitive diagnostic options and to allow more targeted therapeutic measures. The understanding of biochemical processes allows a better insight into glaucoma progression to be gained, which will lead to improvements in diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25916477     DOI: 10.1007/s00347-015-0007-9

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  28 in total

1.  Autoreactive antibodies and loss of retinal ganglion cells in rats induced by immunization with ocular antigens.

Authors:  Panagiotis Laspas; Oliver W Gramlich; Harald D Müller; Clemens S Cuny; Philip F Gottschling; Norbert Pfeiffer; H Burkhard Dick; Stephanie C Joachim; Franz H Grus
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-11       Impact factor: 4.799

2.  Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States.

Authors:  Franz H Grus; Stephanie C Joachim; Kai Bruns; Karl J Lackner; Norbert Pfeiffer; Martin B Wax
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

3.  Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma.

Authors:  A H Neufeld
Journal:  Arch Ophthalmol       Date:  1999-08

4.  An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma.

Authors:  X Wang; S S Tay; Y K Ng
Journal:  Exp Brain Res       Date:  2000-06       Impact factor: 1.972

5.  Enhanced characterization of serum autoantibody reactivity following HSP 60 immunization in a rat model of experimental autoimmune glaucoma.

Authors:  S C Joachim; M B Wax; P Seidel; N Pfeiffer; F H Grus
Journal:  Curr Eye Res       Date:  2010-10       Impact factor: 2.424

6.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

7.  Complex autoantibody repertoires in patients with glaucoma.

Authors:  Franz H Grus; Stephanie C Joachim; Esther M Hoffmann; Norbert Pfeiffer
Journal:  Mol Vis       Date:  2004-02-25       Impact factor: 2.367

8.  Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma.

Authors:  E B Dreyer; D Zurakowski; R A Schumer; S M Podos; S A Lipton
Journal:  Arch Ophthalmol       Date:  1996-03

9.  Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes.

Authors:  Jocelyn Chua; Maya Vania; Chui Ming Gemmy Cheung; Marcus Ang; Soon Phaik Chee; Henry Yang; Jing Li; Tina T Wong
Journal:  Mol Vis       Date:  2012-02-11       Impact factor: 2.367

10.  Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens.

Authors:  Stephanie C Joachim; Oliver W Gramlich; Panagiotis Laspas; Heiko Schmid; Sabine Beck; Harald D von Pein; H Burkhard Dick; Norbert Pfeiffer; Franz H Grus
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

View more
  2 in total

1.  Agonistic β2-Adrenergic Receptor Autoantibodies Characterize the Aqueous Humor of Patients With Primary and Secondary Open-Angle Glaucoma.

Authors:  Bettina Hohberger; Max Wörn; Robert Lämmer; Aparna Mahajan; Christian Mardin; Ursula Schötzer-Schrehardt; Rudolph Kunze; Martin Herrmann; Gerd Wallukat
Journal:  Front Immunol       Date:  2021-05-05       Impact factor: 7.561

Review 2.  Antioxidants for the Treatment of Retinal Disease: Summary of Recent Evidence.

Authors:  Patrick Wang; Eric K Chin; David Almeida
Journal:  Clin Ophthalmol       Date:  2021-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.